Literature DB >> 10331102

MRI anatomy of schizophrenia.

R W McCarley1, C G Wible, M Frumin, Y Hirayasu, J J Levitt, I A Fischer, M E Shenton.   

Abstract

Structural magnetic resonance imaging (MRI) data have provided much evidence in support of our current view that schizophrenia is a brain disorder with altered brain structure, and consequently involving more than a simple disturbance in neurotransmission. This review surveys 118 peer-reviewed studies with control group from 1987 to May 1998. Most studies (81%) do not find abnormalities of whole brain/intracranial contents, while lateral ventricle enlargement is reported in 77%, and third ventricle enlargement in 67%. The temporal lobe was the brain parenchymal region with the most consistently documented abnormalities. Volume decreases were found in 62% of 37 studies of whole temporal lobe, and in 81% of 16 studies of the superior temporal gyrus (and in 100% with gray matter separately evaluated). Fully 77% of the 30 studies of the medial temporal lobe reported volume reduction in one or more of its constituent structures (hippocampus, amygdala, parahippocampal gyrus). Despite evidence for frontal lobe functional abnormalities, structural MRI investigations less consistently found abnormalities, with 55% describing volume reduction. It may be that frontal lobe volume changes are small, and near the threshold for MRI detection. The parietal and occipital lobes were much less studied; about half of the studies showed positive findings. Most studies of cortical gray matter (86%) found volume reductions were not diffuse, but more pronounced in certain areas. About two thirds of the studies of subcortical structures of thalamus, corpus callosum and basal ganglia (which tend to increase volume with typical neuroleptics), show positive findings, as do almost all (91%) studies of cavum septi pellucidi (CSP). Most data were consistent with a developmental model, but growing evidence was compatible also with progressive, neurodegenerative features, suggesting a "two-hit" model of schizophrenia, for which a cellular hypothesis is discussed. The relationship of clinical symptoms to MRI findings is reviewed, as is the growing evidence suggesting structural abnormalities differ in affective (bipolar) psychosis and schizophrenia.

Entities:  

Mesh:

Year:  1999        PMID: 10331102      PMCID: PMC2846838          DOI: 10.1016/s0006-3223(99)00018-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  157 in total

Review 1.  Temporal lobe asymmetries as the key to the etiology of schizophrenia.

Authors:  T J Crow
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

Review 2.  Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions.

Authors:  D C Steffens; K R Krishnan
Journal:  Biol Psychiatry       Date:  1998-05-15       Impact factor: 13.382

3.  Quantitative MRI volume changes in late onset schizophrenia and Alzheimer's disease compared to normal controls.

Authors:  P E Barta; R E Powers; E H Aylward; G A Chase; G J Harris; P V Rabins; L E Tune; G D Pearlson
Journal:  Psychiatry Res       Date:  1997-02-07       Impact factor: 3.222

4.  Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine.

Authors:  M H Chakos; J A Lieberman; J Alvir; R Bilder; M Ashtari
Journal:  Lancet       Date:  1995-02-18       Impact factor: 79.321

5.  A magnetic resonance imaging study of schizophrenia: brain structure and clinical symptoms.

Authors:  A H Young; D H Blackwood; H Roxborough; J K McQueen; M J Martin; D Kean
Journal:  Br J Psychiatry       Date:  1991-02       Impact factor: 9.319

Review 6.  Schizophrenia and nicotinic receptors.

Authors:  R Freedman; L E Adler; P Bickford; W Byerley; H Coon; C M Cullum; J M Griffith; J G Harris; S Leonard; C Miller
Journal:  Harv Rev Psychiatry       Date:  1994 Nov-Dec       Impact factor: 3.732

7.  Structural magnetic resonance imaging abnormalities in men with severe chronic schizophrenia and an early age at clinical onset.

Authors:  L Marsh; D Harris; K O Lim; M Beal; A L Hoff; K Minn; J G Csernansky; S DeMent; W O Faustman; E V Sullivan; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  1997-12

8.  Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients.

Authors:  G Degreef; M Ashtari; B Bogerts; R M Bilder; D N Jody; J M Alvir; J A Lieberman
Journal:  Arch Gen Psychiatry       Date:  1992-07

9.  Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study.

Authors:  V W Swayze; N C Andreasen; R J Alliger; W T Yuh; J C Ehrhardt
Journal:  Biol Psychiatry       Date:  1992-02-01       Impact factor: 13.382

10.  Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study.

Authors:  L E DeLisi; A L Hoff; J E Schwartz; G W Shields; S N Halthore; S M Gupta; F A Henn; A K Anand
Journal:  Biol Psychiatry       Date:  1991-01-15       Impact factor: 13.382

View more
  149 in total

1.  Large CSF volume not attributable to ventricular volume in schizotypal personality disorder.

Authors:  C C Dickey; M E Shenton; Y Hirayasu; I Fischer; M M Voglmaier; M A Niznikiewicz; L J Seidman; S Fraone; R W McCarley
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

2.  BrainImageJ: a Java-based framework for interoperability in neuroscience, with specific application to neuroimaging.

Authors:  Y R Ng; S Shiffman; T J Brosnan; J M Links; L S Beach; N S Judge; Y Xu; U V Kelkar; A L Reiss
Journal:  J Am Med Inform Assoc       Date:  2001 Sep-Oct       Impact factor: 4.497

3.  Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia.

Authors:  P M Thompson; C Vidal; J N Giedd; P Gochman; J Blumenthal; R Nicolson; A W Toga; J L Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 4.  Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects.

Authors:  R W McCarley; M A Niznikiewicz; D F Salisbury; P G Nestor; B F O'Donnell; Y Hirayasu; H Grunze; R W Greene; M E Shenton
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

5.  A MRI study of fusiform gyrus in schizotypal personality disorder.

Authors:  Chandlee C Dickey; Robert W McCarley; Martina M Voglmaier; Margaret A Niznikiewicz; Larry J Seidman; Melissa Frumin; Sarah Toner; Susan Demeo; Martha E Shenton
Journal:  Schizophr Res       Date:  2003-11-01       Impact factor: 4.939

Review 6.  Hippocampal neurons in schizophrenia.

Authors:  S Heckers; C Konradi
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

7.  Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data.

Authors:  Martha E Shenton; Guido Gerig; Robert W McCarley; Gábor Székely; Ron Kikinis
Journal:  Psychiatry Res       Date:  2002-08-20       Impact factor: 3.222

8.  Smaller left Heschl's gyrus volume in patients with schizotypal personality disorder.

Authors:  Chandlee C Dickey; Robert W McCarley; Martina M Voglmaier; Melissa Frumin; Margaret A Niznikiewicz; Yoshio Hirayasu; Stephanie Fraone; Larry J Seidman; Martha E Shenton
Journal:  Am J Psychiatry       Date:  2002-09       Impact factor: 18.112

9.  Dysregulation of Epigenetic Control Contributes to Schizophrenia-Like Behavior in Ebp1+/- Mice.

Authors:  Inwoo Hwang; Jee-Yin Ahn
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

10.  Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH.

Authors:  Maria Suntsova; Elena V Gogvadze; Sergey Salozhin; Nurshat Gaifullin; Fedor Eroshkin; Sergey E Dmitriev; Natalia Martynova; Kirill Kulikov; Galina Malakhova; Gulnur Tukhbatova; Alexey P Bolshakov; Dmitry Ghilarov; Andrew Garazha; Alexander Aliper; Charles R Cantor; Yuri Solokhin; Sergey Roumiantsev; Pavel Balaban; Alex Zhavoronkov; Anton Buzdin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.